{ "cik": 1356576, "cik_padded": "0001356576", "entityName": "SUPERNUS PHARMACEUTICALS, INC.", "fiscal_years": [ { "accn": "0001356576-26-000011", "filed": "2026-03-02", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1338000.0, "cash": 128448000.0, "eps_diluted": -0.68, "free_cash_flow": 45993000.0, "net_income": -38550000.0, "operating_cash_flow": 47331000.0, "operating_income": -62283000.0, "revenue": 718952000.0, "stockholders_equity": 1061714000.0, "total_assets": 1452648000.0, "total_liabilities": 390934000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.36821027131600415, "net_margin": -0.053619713138012, "operating_margin": -0.08663026182554608, "revenue_growth_yoy": 0.08633051130448448, "roa_avg2y": -0.027333437089311564, "roa_period_end": -0.026537743486377982, "roe_avg2y": -0.03675897412425678, "roe_period_end": -0.03630921321561174 } }, { "accn": "0001356576-26-000011", "filed": "2026-03-02", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 725000.0, "cash": 69331000.0, "eps_diluted": 1.32, "free_cash_flow": 171226000.0, "net_income": 73865000.0, "operating_cash_flow": 171951000.0, "operating_income": 81666000.0, "revenue": 661817000.0, "stockholders_equity": 1035733000.0, "total_assets": 1368073000.0, "total_liabilities": 332340000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.32087420213510626, "net_margin": 0.11160940259920794, "operating_margin": 0.12339664892258737, "revenue_growth_yoy": 0.08937304224874532, "roa_avg2y": 0.05583680368410271, "roa_period_end": 0.053992001888788096, "roe_avg2y": 0.07547838828886871, "roe_period_end": 0.07131664241653013 } }, { "accn": "0001356576-26-000011", "filed": "2026-03-02", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 551000.0, "cash": 75054000.0, "eps_diluted": 0.02, "free_cash_flow": 110534000.0, "net_income": 1316000.0, "operating_cash_flow": 111085000.0, "operating_income": -5269000.0, "revenue": 607521000.0, "stockholders_equity": 921516000.0, "total_assets": 1277673000.0, "total_liabilities": 356157000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.38649030510593413, "net_margin": 0.002166180263727509, "operating_margin": -0.008672951223085293, "revenue_growth_yoy": -0.08949879952880381, "roa_avg2y": 0.0008831678344369017, "roa_period_end": 0.0010299975032735293, "roe_avg2y": 0.0014559776956608323, "roe_period_end": 0.0014280815525720661 } }, { "accn": "0001356576-26-000011", "filed": "2026-03-02", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 412000.0, "cash": 93120000.0, "eps_diluted": 1.04, "free_cash_flow": 116414000.0, "net_income": 60711000.0, "operating_cash_flow": 116826000.0, "operating_income": 46124000.0, "revenue": 667238000.0, "stockholders_equity": 886204000.0, "total_assets": 1702508000.0, "total_liabilities": 816304000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.9211242558146883, "net_margin": 0.09098852283592959, "operating_margin": 0.06912675836807855, "revenue_growth_yoy": 0.15085679789573542, "roa_avg2y": 0.03580016864898015, "roa_period_end": 0.03565974433012943, "roe_avg2y": 0.07133847026094926, "roe_period_end": 0.06850679978876195 } }, { "accn": "0001356576-25-000017", "filed": "2025-02-25", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 203434000.0, "eps_diluted": 0.98, "net_income": 53424000.0, "operating_cash_flow": 127127000.0, "operating_income": 86029000.0, "revenue": 579775000.0, "stockholders_equity": 815851000.0, "total_assets": 1689152000.0, "total_liabilities": 873301000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.070417269820102, "net_margin": 0.09214609115605192, "operating_margin": 0.1483834246043724, "revenue_growth_yoy": 0.11410134954659616, "roa_avg2y": 0.033460538998776795, "roa_period_end": 0.03162770431553821, "roe_avg2y": 0.06846119295781597, "roe_period_end": 0.06548254521965408 } }, { "accn": "0001356576-23-000016", "filed": "2023-03-09", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 3449000.0, "cash": 288640000.0, "eps_diluted": 2.36, "free_cash_flow": 134950000.0, "net_income": 126950000.0, "operating_cash_flow": 138399000.0, "operating_income": 173698000.0, "revenue": 520397000.0, "stockholders_equity": 744858000.0, "total_assets": 1504102000.0, "total_liabilities": 759244000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.019313748392311, "net_margin": 0.24394837018660753, "operating_margin": 0.33377978735465424, "revenue_growth_yoy": 0.3249914068566918, "roa_avg2y": 0.09529407172539694, "roa_period_end": 0.08440252057373769, "roe_avg2y": 0.18943717982579839, "roe_period_end": 0.17043517019351342 } }, { "accn": "0001356576-23-000016", "filed": "2023-03-09", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2736000.0, "cash": 181381000.0, "eps_diluted": 2.1, "free_cash_flow": 140393000.0, "net_income": 113056000.0, "operating_cash_flow": 143129000.0, "operating_income": 148571000.0, "revenue": 392755000.0, "stockholders_equity": 595428000.0, "total_assets": 1160282000.0, "total_liabilities": 564854000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.9486520620461248, "net_margin": 0.2878537510661863, "operating_margin": 0.37827907983348397, "revenue_growth_yoy": -0.03947693428907524, "roa_avg2y": 0.10575405279377464, "roa_period_end": 0.09743838135901445, "roe_avg2y": 0.21566291605425528, "roe_period_end": 0.1898735027576802 } }, { "accn": "0001356576-22-000025", "filed": "2022-04-13", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 844000.0, "cash": 192248000.0, "eps_diluted": 2.05, "free_cash_flow": 128142000.0, "net_income": 110993000.0, "operating_cash_flow": 128986000.0, "operating_income": 144444000.0, "revenue": 408897000.0, "stockholders_equity": 453023000.0, "total_assets": 977811000.0, "total_liabilities": 524788000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.1584135904799535, "net_margin": 0.271444887098707, "operating_margin": 0.35325277514875386, "roa_avg2y": 0.1583041842719866, "roa_period_end": 0.11351171136344344, "roe_avg2y": 0.30809864775025225, "roe_period_end": 0.2450052204854941 } }, { "accn": "0001356576-21-000028", "filed": "2021-03-08", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2029000.0, "cash": 100304000.0, "eps_diluted": 1.08, "free_cash_flow": 112611000.0, "net_income": 57284000.0, "operating_cash_flow": 114640000.0, "operating_income": 99541000.0, "stockholders_equity": 267480000.0, "total_assets": 424464000.0, "total_liabilities": 156984000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.5868999551368327, "roa_avg2y": 0.1560803888658805, "roa_period_end": 0.13495608579290588, "roe_avg2y": 0.24947575859853888, "roe_period_end": 0.2141618064902049 } }, { "accn": "0001356576-20-000010", "filed": "2020-02-28", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1603000.0, "cash": 66398000.0, "eps_diluted": 1.76, "free_cash_flow": 65209000.0, "net_income": 91221000.0, "operating_cash_flow": 66812000.0, "operating_income": 54216000.0, "stockholders_equity": 191755000.0, "total_assets": 309568000.0, "total_liabilities": 117813000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.6143933665354228, "roa_period_end": 0.2946719299152367, "roe_period_end": 0.4757164089593492 } }, { "accn": "0001047469-18-001210", "filed": "2018-03-01", "fiscal_year": 2015, "form": "10-K", "fundamental_units": { "capex": "USD" }, "fundamentals": { "capex": 2104000.0 }, "period_end": "2015-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001356576-26-000011", "filed": "2026-03-02", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001356576.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001356576.json" }, "ticker": "SUPN" }